Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells.
D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic; D005347:Fibroblasts / Q000502:physiology*; D017228:Hepatocyte Growth Factor / Q000096:biosynthesis / Q000494:pharmacology; D006801:Humans; D007150:Immunohistochemistry; D009062:Mouth Neoplasms / Q000473:pathology*; D009130:Muscle, Smooth / Q000166:cytology; D009361:Neoplasm Invasiveness; D010641:Phenotype; D017154:Stromal Cells; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D016212:Transforming Growth Factor beta; D017228:Hepatocyte Growth Factor